What are the recommended doses of paralytic (e.g. rocuronium) and sedative (e.g. propofol) for intubation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Doses for Intubation

For rapid sequence intubation, use rocuronium 0.9-1.2 mg/kg (or succinylcholine 1.0 mg/kg in adults) combined with propofol 2 mg/kg and remifentanil 2 μg/kg for optimal intubation conditions. 1, 2, 3, 4

Paralytic Agent Dosing

Rocuronium (Preferred in Most Settings)

Standard Rapid Sequence Intubation:

  • Dose: 0.9-1.2 mg/kg IV for excellent intubation conditions within 60 seconds 1, 2, 4
  • Lower doses (0.6 mg/kg) provide adequate conditions but with slower onset (median 1 minute vs. immediate with higher doses) 4
  • The 0.6 mg/kg dose is acceptable for non-emergent intubations where 2-3 minutes to optimal conditions is acceptable 4

Pediatric Dosing:

  • Rapid sequence intubation: >0.9 mg/kg (same as adults when succinylcholine is contraindicated) 1, 2
  • Routine paralysis: 0.1 mg/kg 1
  • Standard intubation: 0.2 mg/kg 1

Key Advantage: Rocuronium at 1.2 mg/kg provides comparable first-pass success rates to succinylcholine with minimal cardiovascular effects, though duration is longer (30-60 minutes vs. 4-6 minutes) 3, 4

Succinylcholine (Alternative When Not Contraindicated)

Adult Dosing:

  • Standard dose: 1.0 mg/kg IV for rapid sequence intubation 3
  • Provides fastest onset and shortest duration of all paralytics 3

Pediatric Dosing (Age-Specific):

  • <1 month: 1.8 mg/kg 2, 3
  • 1 month to 1 year: 2.0 mg/kg 2, 3
  • 1-10 years: 1.2 mg/kg 2, 3
  • >10 years: 1.0 mg/kg 2, 3

Absolute Contraindications:

  • History of malignant hyperthermia 3
  • Primary muscle damage (myopathies, Duchenne muscular dystrophy) 5, 3
  • Immobilization >3 days, burns, crush injuries, spinal cord injuries (risk of fatal hyperkalemia) 3
  • Up-regulation of nicotinic acetylcholine receptors from chronic motor deficit 5

Sedative Agent Dosing

Propofol (Primary Induction Agent)

Standard Dose: 2 mg/kg IV for induction 6

  • When combined with remifentanil 2 μg/kg and rocuronium 0.9-1.2 mg/kg, provides superior intubation conditions compared to thiopental-based regimens 7
  • The propofol-rocuronium combination is significantly more effective than thiopental-rocuronium for rapid sequence intubation 7

Remifentanil (Adjunct Opioid)

Standard Dose: 2 μg/kg IV given 15 seconds before intubation attempt 6, 8

  • Improves intubation conditions when combined with propofol and rocuronium 6
  • Allows for lower doses of paralytic while maintaining acceptable conditions 6

Critical Timing Considerations

True Rapid Sequence Intubation Protocol:

  1. Administer propofol 2 mg/kg IV 6
  2. Immediately follow with rocuronium 0.9-1.2 mg/kg (or succinylcholine 1.0 mg/kg) 1, 4
  3. Give remifentanil 2 μg/kg 15 seconds before intubation attempt 6
  4. Attempt intubation at 60 seconds after rocuronium administration 4, 7

Important: The intubation model matters significantly—true RSI (immediate administration of paralytic after hypnotic with intubation within 60 seconds) requires higher rocuronium doses (0.9-1.2 mg/kg) for success comparable to succinylcholine 7

Special Population Adjustments

Renal or Hepatic Failure

  • Do NOT modify the initial dose of rocuronium—time to onset remains unchanged despite prolonged duration of action 5, 1
  • Consider using atracurium or cisatracurium for maintenance dosing due to organ-independent elimination 5

Cardiovascular Instability

  • Rocuronium 0.6 mg/kg has minimal cardiovascular effects and can be used safely 1
  • Large bolus doses (0.9-1.2 mg/kg) can be administered without adverse cardiovascular effects 4

Pediatric Considerations

  • Always have atropine available for children aged 28 days to 8 years, particularly with succinylcholine use (prevents bradycardia) 3
  • Neuromuscular monitoring is essential—28% of pediatric patients develop residual blockade 2
  • Flush IV tubing with saline before administering rocuronium after other medications to prevent precipitation 1, 2

Common Pitfalls to Avoid

Inadequate Dosing:

  • Using rocuronium 0.6 mg/kg for true RSI with thiopental induction results in poor conditions in 31% of patients 7
  • The ED50 of rocuronium with propofol-remifentanil is only 0.20 mg/kg, but clinical dosing should be 0.8 mg/kg minimum for reliable conditions 6

Timing Errors:

  • Attempting intubation before 60 seconds with standard rocuronium doses leads to suboptimal conditions 4, 7
  • Modified RSI (delayed administration) requires different dosing considerations than true RSI 7

Reversal Preparedness:

  • Sugammadex must be immediately available when using rocuronium, especially in pediatrics, to allow reversal if needed 2, 3
  • Dantrolene must be available wherever succinylcholine is used (malignant hyperthermia risk) 3

Lack of Monitoring:

  • Personnel skilled in airway management must be present 1, 2
  • Age-appropriate equipment for suctioning, oxygenation, and ventilation must be immediately available 1, 2
  • Remember: Rocuronium provides NO sedation, analgesia, or amnesia—concurrent sedative/analgesic agents are mandatory 1, 2

References

Guideline

Rocuronium Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rocuronium Dosage for Pediatric Intubation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Succinylcholine Use and Side Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.